We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
32 hedge funds and large institutions have $213M invested in ESSA Pharma in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
15% more capital invested
Capital invested by funds: $185M → $213M (+$27.6M)
3% more funds holding
Funds holding: 31 → 32 (+1)
0.26% less ownership
Funds ownership: 79.37% → 79.11% (-0.26%)
46% less call options, than puts
Call options by funds: $120K | Put options by funds: $224K
Holders
32
Holders Change
+1
Holders Change %
+3.23%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
10
Reduced
7
Closed
3
Calls
$120K
Puts
$224K
Net Calls
-$104K
Net Calls Change
-$329K
Top Buyers
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$5.19M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$1.22M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$207K |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$54.9K |
| 5 |
Two Sigma Investments
New York
|
-$54.2K |
